Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2023 ∙ Abdelhady, M. Husain, M. A. Hawas, Y. Elazb, M. A. Mansour, L. S. Mohamed, M. Abdelwahab, M. M. Aljabali, A. Negida, A.

Encephalitis following COVID-19 Vaccination: A Systematic Review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Wang, H. Dewidar, O. Whittle, S. L. Ghogomu, E. Hazlewood, G. Leder, K. Mbuagbaw, L. Pardo Pardo, J. Robinson, P. C. Buchbinder, R. Welch, V.

Equity Considerations in COVID-19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases

  • Adults
  • Older adults
  • COVID-19
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Patikorn, C. Cho, J. Y. Lambach, P. Hutubessy, R. Chaiyakunapruk, N.

Equity-Informative Economic Evaluations of Vaccines: A Systematic Literature Review

  • All age groups
  • Economic aspects
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Alahmad, G.

Ethical Challenges Involved in COVID-19 Vaccine Mandates for Children: A Systematic Review

  • Children
  • Parents/caregivers
  • COVID-19
  • Ethical issues
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Murali, Mayur Gumber, Leher Jethwa, Hannah Ganesh, Divolka Hartmann-Boyce, Jamie Sood, Harpreet Zaccardi, Francesco Khunti, Kamlesh

Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis

  • Europe
  • United Kingdom
  • Adults
  • Older adults
  • COVID-19
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Grabenstein, J. D. Ferrara, P. Mantovani, L. G. McGovern, I.

Evaluating risk of bias using ROBINS-I tool in nonrandomized studies of adjuvanted influenza vaccine

  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Tiozzo, Giorgia Louwsma, Timon Konings, Stefan R. A. Vondeling, Gerard T. Perez Gomez, Judith Postma, Maarten J. Freriks, Roel D.

Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Suhail, M. K. Moinuddin, A.

Evaluation of strategies against vaccine hesitancy in the COVID-19 and Indian context-A systematic review

  • South-East Asia
  • India
  • All age groups
  • COVID-19
  • Poliomyelitis
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Lu, D. Han, Y. Xu, R. Qin, M. Shi, J. Zhang, C. Zhang, J. Ye, F. Luo, Z. Wang, Y. Wang, C.

Evaluation of the efficacy, safety and influencing factors of concomitant and sequential administration of viral respiratory infectious disease vaccines: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Moderate
2023 ∙ Menegale, F. Manica, M. Zardini, A. Guzzetta, G. Marziano, V. d'Andrea, V. Trentini, F. Ajelli, M. Poletti, P. Merler, S.

Evaluation of Waning of SARS-CoV-2 Vaccine-Induced Immunity: A Systematic Review and Meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...